Expert insights. Personalized for you.
Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. NEW YORK, Jan. 21, 2021 /PRNewswire/ — DarioHealth Corp. MORE
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching. MORE
a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digital therapeutics platform. MORE
DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans. The post [DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes appeared first on OurCrowd. MORE
Nasdaq: DRIO), (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. DarioHealth Corp. MORE
Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching. MORE
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). DarioHealth Corp. MORE
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. MORE
The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap. MORE
The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform. MORE
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp. MORE
MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ). MORE
Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. MORE
Medisafe, a Boston, MA-based digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform. MORE
3, 2021 /PRNewswire/ — Medisafe, a leading digital therapeutics company, named Best Medication Reminder App by OnlineDoctor.com while AVA Digital Awards named Medisafe a Platinum Award Winner in the ‘App for Medical’ category. BOSTON, Feb. MORE
NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp. MORE
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. MORE
Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources. MORE
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. MORE
Real-world results show users prefer to wait on COVID-19 vaccine dose, refer to a physician for guidance on timing, according to a new survey from Medisafe, a digital therapeutics platform that supports users with advanced medication management. MORE
BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here. MORE
BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19. Read more here. MORE
Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform. MORE
Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here. MORE
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) ”) as part of its UK Israel Dangoor Health Initiative (the “Initiative”), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients. MORE
Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis. MORE
DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. MORE
NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference on March 11, 2021. NEW YORK, March 5, 2021 /PRNewswire/ — DarioHealth Corp. MORE
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. MORE
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here. MORE
In addition, the FDA demands your plan for testing the product’s safety and efficacy in humans throughout the three Phases of therapeutic clinical trials 2. We describe the major ones here: Therapeutic Submissions. Emerging Therapeutic Areas. Digital Health. MORE
NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp. MORE
Today’s entrepreneur is Omri Shor is co-founder and CEO of Medisafe, a digital therapeutic companion company helping patients manage their treatment journey and medication therapies, which just raised a $30 million round of funding. MORE
Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its epilepsy medications. MORE
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp. MORE
digital therapeutics Related Topics TechCrunch
DECEMBER 2, 2020
Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis.
OurCrowd
JANUARY 13, 2021
The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OurCrowd
JUNE 18, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m.
OurCrowd
SEPTEMBER 23, 2019
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp.
OurCrowd
JANUARY 21, 2021
Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. NEW YORK, Jan. 21, 2021 /PRNewswire/ — DarioHealth Corp.
OurCrowd
DECEMBER 3, 2019
Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here.
OurCrowd
AUGUST 13, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.
OurCrowd
AUGUST 11, 2019
NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.
OurCrowd
JUNE 14, 2020
Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.
OurCrowd
MAY 6, 2020
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S.
.png)
|
OurCrowd
MAY 4, 2020
NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.
OurCrowd
MARCH 1, 2021
Today’s entrepreneur is Omri Shor is co-founder and CEO of Medisafe, a digital therapeutic companion company helping patients manage their treatment journey and medication therapies, which just raised a $30 million round of funding.
OurCrowd
MAY 6, 2020
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.
OurCrowd
FEBRUARY 3, 2021
3, 2021 /PRNewswire/ — Medisafe, a leading digital therapeutics company, named Best Medication Reminder App by OnlineDoctor.com while AVA Digital Awards named Medisafe a Platinum Award Winner in the ‘App for Medical’ category. BOSTON, Feb.
OurCrowd
FEBRUARY 24, 2020
NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.
OurCrowd
OCTOBER 7, 2020
Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources.
OurCrowd
MARCH 5, 2021
NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference on March 11, 2021. NEW YORK, March 5, 2021 /PRNewswire/ — DarioHealth Corp.
Angel Capital Association
MAY 18, 2020
MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ).
OurCrowd
DECEMBER 22, 2019
The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform.
OurCrowd
SEPTEMBER 16, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). DarioHealth Corp.
OurCrowd
NOVEMBER 15, 2019
Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.
OurCrowd
APRIL 5, 2020
BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19. Read more here.
OurCrowd
NOVEMBER 24, 2020
Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its epilepsy medications.
OurCrowd
SEPTEMBER 9, 2020
Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform.
OurCrowd
SEPTEMBER 15, 2020
a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digital therapeutics platform.
OurCrowd
SEPTEMBER 10, 2020
Medisafe, a Boston, MA-based digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform.
OurCrowd
NOVEMBER 15, 2019
DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans. The post [DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes appeared first on OurCrowd.
OurCrowd
JULY 30, 2019
DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels.
OurCrowd
JULY 30, 2019
Nasdaq: DRIO), (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. DarioHealth Corp.
OurCrowd
OCTOBER 24, 2019
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.
OurCrowd
SEPTEMBER 18, 2019
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.
OurCrowd
AUGUST 15, 2019
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) ”) as part of its UK Israel Dangoor Health Initiative (the “Initiative”), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients.
Y Combinator
MARCH 2, 2021
In addition, the FDA demands your plan for testing the product’s safety and efficacy in humans throughout the three Phases of therapeutic clinical trials 2. We describe the major ones here: Therapeutic Submissions. Emerging Therapeutic Areas. Digital Health.
OurCrowd
OCTOBER 16, 2020
Real-world results show users prefer to wait on COVID-19 vaccine dose, refer to a physician for guidance on timing, according to a new survey from Medisafe, a digital therapeutics platform that supports users with advanced medication management.
36 
Let's personalize your content